Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-tumor therapy of glycyrrhetinic acid targeted liposome co-delivery of doxorubicin and berberine for hepatocellular carcinoma

Published:2024-01-18 Issue:9 Volume:14 Page:2386-2402
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Xu Na^ORCID,Wu Jingliang^ORCID,Wang Weihao^ORCID,Sun Shujie,Sun Mengmeng^ORCID,Bian Yandong^ORCID,Zhang Huien^ORCID,Liu Shuzhen^ORCID,Yu Guohua^ORCID

Funder

National Science Foundation of China

Natural Science Foundation of Shandong Province

the Science and Technology Development Program in Weifang

Scientific Research Project of Weifang University of Science and Technology

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13346-023-01512-7.pdf

Reference76 articles.

1. Mortality Database, World Health Organization. 2020. https://platform.who.int/mortality/themes/theme-details. Accessed 20 Apr 2023.

2. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

3. de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403. https://doi.org/10.1016/j.ccell.2023.02.016.

4. Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5:166. https://doi.org/10.1038/s41392-020-00280-x.

5. Hui L, Chen Y. Tumor microenvironment: sanctuary of the devil. Cancer Lett. 2015;368:7–13. https://doi.org/10.1016/j.canlet.2015.07.039.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating Chinese medicine into mainstream cancer therapies: a promising future;Frontiers in Oncology;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3